Patent details

Basic Information

Publication number:

EP1482948

PCT Application Number:

PCT/US/2003/007452

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037164670

PCT Publication Number:

WO/2003/077924

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CONTINUOUS SULFATASE INHIBITING PROGESTOGEN HORMONE REPLACEMENT THERAPY

French Title of Invention:

TRAITEMENT HORMONAL SUBSTITUTIF CONTINU PAR PROGESTOGENE INHIBANT LA SULFATASE

German Title of Invention:

KONTINUIERLICHE SULFATASE-HEMMENDE PROGESTOGEN ENTHALTENDE HORMONSUBSTITUTIONS-THERAPIE

SPC Number:

Dates

Filing date:

11/03/2003

Grant date:

16/08/2006

EP Publication Date:

16/08/2006

PCT Publication Date:

25/09/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/12/2004

EP B1 Publication Date:

16/08/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/03/2018

Expiration date:

11/03/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/03/2003

 

 

Name:

JANSSEN PHARMACEUTICA N.V.

Address:

Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Inventor

1

Name:

CAUBEL Patrick, Michel

Address:

United States (US)

2

Name:

FRIEDMEN Andrew, Joseph

Address:

United States (US)

Priority

1

Priority Number:

363148 P

Priority Date:

11/03/2002

Priority Country:

United States (US)

2

Priority Number:

381541 P

Priority Date:

17/05/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/565;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/02/2017

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1